首页> 外文期刊>Analytical chemistry >Combination Strategy of Reactive and Catalytic Matrices for Qualitative and Quantitative Profiling of N-Glycans in MALDI-MS
【24h】

Combination Strategy of Reactive and Catalytic Matrices for Qualitative and Quantitative Profiling of N-Glycans in MALDI-MS

机译:MALDI-MS中N-聚糖定性和定量析谱的反应性和催化基质的组合策略

获取原文
获取原文并翻译 | 示例
       

摘要

Qualitative and quantitative analysis of N-glycans by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) is hampered mainly by the low ionization efficiency of analytes and their poor cocrystallization with traditional organic acid matrices. In the present study, a combination strategy of reactive and catalytic matrices (CSRCM) was proposed for the on-target derivatization and detection of reducing N-glycans: a novel reactive matrix, i.e., 2,5-dihydroxybenzohydrazide (DHBH), having a skeleton structure similar to that of DHB, was designed and synthesized, and this reactive matrix was mixed with catalytic matrix DHB to form a rationally combinatorial matrix (DHB/DHBH). Qualitatively, DHB/DHBH could improve the ionization efficiency of reducing carbohydrates significantly. Quantitatively, the acid base chemistry of DHB/DHBH leads to a uniform cocrystallization of analytes-matrix mixtures. Consequently, CSRCM provides accurate quantitation for N-glycans with high derivatization efficiency and good linearity (R-2 > 0.99) within 2 orders of magnitude on the basis of an internal standard method. Furthermore, the CSRCM was successfully applied to evaluating N-glycan in serum samples of colorectal cancer patients, thus showing potential in clinical applications for biomarker discovery.
机译:通过基质辅助激光解吸/电离质谱(MALDI-MS)对N-聚糖的定性和定量分析主要是通过分析物的低电离效率和与传统有机酸基质的低电离效率而受到阻碍。在本研究中,提出了反应性和催化基质(CSRCM)的组合策略,用于靶向衍生化和减少N-聚糖的检测:一种新型反应基质,即2,5-二羟基苯甲酰肼(DHBH),具有a设计和合成了类似于DHB的骨架结构,并与催化基质DHB混合,形成合理组合基质(DHB / DHBH)。定性地,DHB / DHBH可以提高显着降低碳水化合物的电离效率。定量地,DHB / DHBH的酸碱化学导致分析物 - 基质混合物的均匀的COCRYALIZ化。因此,CSRCM在基于内部标准方法的基础上,CSRCM为具有高衍生效率和具有高衍生效率和良好线性(R-2> 0.99)的N-聚糖的准确定量。此外,CSRCM已成功应用于在结肠直肠癌患者的血清样本中评估N-聚糖,从而显示出生物标志物发现的临床应用中的潜力。

著录项

  • 来源
    《Analytical chemistry》 |2019年第14期|共8页
  • 作者单位

    Zhejiang Univ Dept Chem Hangzhou 310027 Zhejiang Peoples R China;

    Zhejiang Univ Key Lab Canc Prevent &

    Intervent China Natl Minist Educ Canc Inst Sch Med Affiliated Hosp 2 Hangzhou 310009 Zhejiang Peoples R China;

    Zhejiang Univ Dept Chem Hangzhou 310027 Zhejiang Peoples R China;

    Zhejiang Univ Dept Chem Hangzhou 310027 Zhejiang Peoples R China;

    Zhejiang Univ Dept Chem Hangzhou 310027 Zhejiang Peoples R China;

    Zhejiang Univ Dept Chem Hangzhou 310027 Zhejiang Peoples R China;

    Zhejiang Univ Dept Chem Hangzhou 310027 Zhejiang Peoples R China;

    Zhejiang Univ Dept Chem Hangzhou 310027 Zhejiang Peoples R China;

    Zhejiang Univ Coll Agr &

    Biotechnol Hangzhou 310058 Zhejiang Peoples R China;

    Zhejiang Univ Dept Chem Hangzhou 310027 Zhejiang Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分析化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号